INBS vs. SRTS, SURG, PYPD, DXR, CTCX, MDAI, APT, ZYXI, GUTS, and MLSS
Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include Sensus Healthcare (SRTS), SurgePays (SURG), PolyPid (PYPD), Daxor (DXR), Carmell (CTCX), Spectral AI (MDAI), Alpha Pro Tech (APT), Zynex (ZYXI), Fractyl Health (GUTS), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry.
Intelligent Bio Solutions vs. Its Competitors
Sensus Healthcare (NASDAQ:SRTS) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.
Sensus Healthcare has higher revenue and earnings than Intelligent Bio Solutions. Sensus Healthcare is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
Sensus Healthcare presently has a consensus target price of $8.00, suggesting a potential upside of 151.57%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Sensus Healthcare is more favorable than Intelligent Bio Solutions.
25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 8.9% of Sensus Healthcare shares are held by insiders. Comparatively, 1.5% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Sensus Healthcare has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.59, indicating that its share price is 359% more volatile than the S&P 500.
In the previous week, Sensus Healthcare had 4 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 4 mentions for Sensus Healthcare and 0 mentions for Intelligent Bio Solutions. Sensus Healthcare's average media sentiment score of 0.00 equaled Intelligent Bio Solutions'average media sentiment score.
Sensus Healthcare has a net margin of -2.26% compared to Intelligent Bio Solutions' net margin of -346.22%. Sensus Healthcare's return on equity of -1.58% beat Intelligent Bio Solutions' return on equity.
Summary
Sensus Healthcare beats Intelligent Bio Solutions on 11 of the 15 factors compared between the two stocks.
Get Intelligent Bio Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intelligent Bio Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:INBS) was last updated on 9/4/2025 by MarketBeat.com Staff
Free INBS Stock Alerts